On June 2, Intuitive Surgical fell 3.08% in regular trading, trading at $400.765/share, with trading volume of $390 million. The decline was triggered by Deutsche Bank significantly cutting its target price on the stock from $440 to $366, a reduction of approximately 17%, while maintaining a sell rating.

Deutsche Bank's bearish stance contrasts sharply with the broader analyst consensus, which holds an average overweight rating and a mean target price of $573.01 according to FactSet. The aggressive downside target well below the current trading level intensified short-term selling pressure. This follows Goldman Sachs' earlier reduction of its target from $621 to $558 in late May, reflecting a broader reassessment of the company's near-term growth trajectory among major investment banks.

The Health Care Equipment sector added further headwinds, with peer Stryker declining 1.89% in the same session. Intuitive Surgical has now fallen approximately 27% year-to-date, despite reporting solid Q1 results in April with revenue of $2.771 billion, up 22.96% year-over-year, and net income of $826 million, up 17.38%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)